Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.01453
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Immune Checkpoint Inhibitor‐induced Type 1 Diabetes: A Systematic Review and Meta‐analysis

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Reporting of Immune Checkpoint Inhibitor-Associated Myocarditis – Authors' Reply

The Lancet
Medicine
2018English

Histopathologic Characterization of Myocarditis Associated With Immune Checkpoint Inhibitor Therapy

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2020English

Efficacy of Pentoxifylline Treatment for Neonatal Sepsis: A Meta-Analysis of Randomized Controlled Studies

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2019English

Meta-Analysis of Randomized Controlled Trials on Vitamin D Supplement and Cancer Incidence and Mortality

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk

Mayo Clinic Proceedings
Medicine
2020English

Immune Checkpoint Inhibitor-Induced Fanconi Syndrome

Cureus
2020English

Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020

Kidney360
2020English

Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors: A Systematic Review and Meta-Analysis

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy